New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease

K Brassington, S Selemidis, S Bozinovski… - Clinical …, 2019 - portlandpress.com
Chronic obstructive pulmonary disease (COPD) is a disease characterised by persistent
airflow limitation that is not fully reversible and is currently the fourth leading cause of death …

New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.

K Brassington, S Selemidis, S Bozinovski… - Clinical …, 2019 - search.ebscohost.com
Chronic obstructive pulmonary disease (COPD) is a disease characterised by persistent
airflow limitation that is not fully reversible and is currently the fourth leading cause of death …

New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease

K Brassington, S Selemidis… - Clinical …, 2019 - researchrepository.rmit.edu.au
New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive
pulmonary disease - RMIT University Logo image Limit search to: New Search About the …

[HTML][HTML] New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease

K Brassington, S Selemidis, S Bozinovski… - Clinical Science …, 2019 - ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) is a disease characterised by persistent
airflow limitation that is not fully reversible and is currently the fourth leading cause of death …

New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease

K Brassington, S Selemidis… - Clinical science …, 2019 - pubmed.ncbi.nlm.nih.gov
Chronic obstructive pulmonary disease (COPD) is a disease characterised by persistent
airflow limitation that is not fully reversible and is currently the fourth leading cause of death …

New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.

K Brassington, S Selemidis, S Bozinovski… - Clinical Science …, 2019 - europepmc.org
Chronic obstructive pulmonary disease (COPD) is a disease characterised by persistent
airflow limitation that is not fully reversible and is currently the fourth leading cause of death …

New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease

K Brassington, S Selemidis, S Bozinovski, R Vlahos - Clinical Science, 2019 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Chronic obstructive pulmonary disease
(COPD) is a disease characterised by persistent airflow limitation that is not fully reversible …

[PDF][PDF] New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease

K Brassington, S Selemidis, S Bozinovski… - Clinical …, 2019 - pdfs.semanticscholar.org
Chronic obstructive pulmonary disease (COPD) is a disease characterised by persistent
airflow limitation that is not fully reversible and is currently the fourth leading cause of death …

New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease

K Brassington, S Selemidis… - Clinical …, 2019 - researchrepository.rmit.edu.au
New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive
pulmonary disease - RMIT University Logo image Limit search to: New Search About the …

New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.

K Brassington, S Selemidis, S Bozinovski… - Clinical Science …, 2019 - europepmc.org
Chronic obstructive pulmonary disease (COPD) is a disease characterised by persistent
airflow limitation that is not fully reversible and is currently the fourth leading cause of death …